HOME >> BIOLOGY >> NEWS
Other highlights from the July 10 JNCI

Nanobubbles Deliver Targeted Cancer Drugs Using Ultrasound

A new targeted drug delivery method uses ultrasound to image tumors, while also releasing the drug from nanobubbles into the tumor.

Cancer drugs can be targeted to tumors by delivering them in packets of nanoparticles, then releasing them with ultrasound. But this approach can be difficult because it requires a way to image the tumor prior to treatment.

Natalya Rapoport, Ph.D., D.Sc., of the University of Utah in Salt Lake City and colleagues describe a new method of drug delivery that may address this problem. Nanobubbles filled with the chemotherapy drug doxorubicin were injected into mice. The bubbles accumulated in the tumors, where they combined to form larger microbubbles. When exposed to ultrasound, the bubbles generated echoes, which made it possible to image the tumor. The sound energy from the ultrasound popped the bubbles, releasing the drug. In mice treated with this method, the nanobubbles were more effective at blocking tumor growth than other nanoparticle delivery methods.

Microbubble formulations have been developed for combining ultrasonic tumor imaging and ultrasound-enhanced chemotherapeutic treatment, the authors write.

Contact: Natalya Rapoport, natasha.rapoport@m.cc.utah.edu, (801) 581-8990


Gene May Promote Resistance to Chemotherapy Drugs

A gene known as HDAC1 may be a good target for drugs to treat multidrug-resistant neuroblastoma, a cancer that develops in immature nerve cells and is prevalent in children.

Drug resistance could explain why about 50% of high-risk neuroblastoma patients die of the disease. Nino Keshelava, M.D., of Childrens Hospital Los Angeles and colleagues studied several human neuroblastoma cell lines to identify genes that cause drug resistance.

They found that HDAC1 was overexpressed in m
'"/>

Contact: Liz Savage
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
10-Jul-2007


Page: 1 2

Related biology news :

1. Other highlights in the Aug. 7 JNCI
2. Other highlights in the July 24 JNCI
3. Other highlights in JNCI, June 26
4. Other highlights in JNCI, June 12
5. Other highlights from the June 6 JNCI
6. Other highlights in the May 16 JNCI
7. Other highlights from the April 18 Journal of the National Cancer Institute
8. Other highlights from the March 21 JNCI
9. Other highlights in the March 7 JNCI
10. Other highlights in the Feb. 21 JNCI
11. Other highlights in the Jan. 17 JNCI

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/18/2019)... ... December 17, 2019 , ... PM360, a leading trade magazine ... has named Pharmafusion LLC as one of the most innovative startups of 2019. ... founder/CEO Jonathan Retano. Earlier in the year, Pharmafusion was featured as one of ...
(Date:12/14/2019)... ... 12, 2019 , ... Crop Enhancement Inc., an ... Jean Pougnier as chief business officer. Mr. Pougnier will lead the company’s efforts ... will position the company for maximum commercial success. As part of the expansion ...
(Date:12/4/2019)... ... December 04, 2019 , ... ... launched Subnovii Advanced Plasma Technology for U.S. dermatologists, plastic surgeons and ... the only plasma to employ LF technology – low frequency plus a patented ...
Breaking Biology News(10 mins):
(Date:12/30/2019)... TOWNSHIP, N.J. (PRWEB) , ... December 30, 2019 ... ... of custom built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, Medical Device ... SIMS Version 1.11.19 21 CFR Part 11 compliant software program specific to the ...
(Date:12/18/2019)... ... December 17, 2019 , ... Philadelphia ... to announce that it has hired Dr. Alia Orbin, Ph.D., J.D., an experienced ... in the preparation, filing and prosecution of patent applications related to pharmaceutical sciences, ...
(Date:12/4/2019)... United Kingdom (PRWEB) , ... December 03, 2019 ... ... of recombinant antibody products and services, today announced a partnership with the Recombinant ... Chicago, University of Toronto, and UC San Francisco (UCSF) with a common goal ...
(Date:12/2/2019)... ... December 02, 2019 , ... Registration is now ... Meeting, which will be held at the Hynes Convention Center May 12-15, 2020, in ... therapy and brings together scientists, physicians, patient advocates, and other stakeholders with the goal ...
Breaking Biology Technology:
Cached News: